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Effect of parathyroid hormone on phosphate reabsorption in the
presence of acetazolamide. The hypothesis that parathyroid hor-
mone and carbonic anhydrase inhibitors have a common mecha-
nism or site of action on phosphate reabsorption by the renal
tubule was tested by administration of parathyroid hormone in the
absence and presence of acetazolamide in thyroparathyroidecto-
mized dogs. Re-collection micropuncture and electron probe mi-
croanalysis methodologies were utilized. In the absence of aceta-
zolamide, parathyroid hormone increased fractional delivery of
phosphate (and volume) from the proximal tubule from 28 2 to
38 3%, P < 0.025, and increased fractional phosphate excretion
from 3.8 + 1.2 to 19.9 3.7%, P < 0.005 (eight dogs). In the
presence of acetazolamide, parathyroid hormone increased frac-
tional delivery of phosphate (but not volume) from the proximal
tubule from 50 + 4 to 58 + 5%, P < 0.025, and increased fractional
excretion of phosphate from 8.7 2.2 to 31.0 + 4.3%, P < 0.001
(12 dogs). Thus, the effects of parathyroid hormone were additive
to the effects of maximal inhibition of carbonic anhydrase in-
dicating that parathyroid hormone and carbonic anhydrase inhib-
itors have different mechanisms of action on phosphate reabsorp-
tion by the renal tubule. In addition, phosphate reabsorption
beyond the point of micropuncture in the late proximal tubule was
much more markedly inhibited by parathyroid hormone than by
acetazolamide.
Effet de ('hormone parathyroidienne sur Ia reabsorption du phos-
phate en presence d'acétazolamide. L'hypothèse scIon laquelle
l'hormone parathyroidienne et les inhibiteurs de l'anhydrase car-
bonique partagent un même mécanisme ou un mme site d'action
sur Ia reabsorption du phosphate par le tube renal a étê étudiée
au moyen de l'administration d'hormone parathyroldienne en
l'absence et en presence d'acétazolamide chez des chiens thy-
roparathyroidectomises. Les recollections de microponctions
et Ia microsonde électronique ont été utilisées. En l'absence
d'acCtazolamide, I'hormone parathyroidienne augmente le debit
fractionnel de phosphate (et d'eau) qui quitte Ic tube proximal de
28 2% a 38 + 3%; P < 0,025 et augmente I'excrétion fractionnelle
du phosphate de 3,8 + 1,2% a 19,9 + 3,7%, P <0,005 (huit chiens).
En presence d'acCtazolamide, l'hormone parathyrofdienne aug-
mente Ic debit fractionnel de phosphate (mais non celui d'eau) qui
quitte Ic tube proximal de 50 + 4% a 58 + 5%, P < 0,025 et
augmente l'excrCtion fractionnelle de phosphate de 8,7 + 2,2% a
31,0 + 4,3%, P < 0,001(12 chiens). Ainsi les effets de l'hormone
parathyroldienne s'ajoutent aux effets de l'inhibition maximale de
I'anhydrase carbonique, cc qui indique que I'hormone para-
thyroldienne et les inhibiteurs de l'anhydrasc carbonique wit des
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mCcanismes d'action différents sur Ia reabsorption tubulaire rCnale
du phosphate. De plus, la reabsorption de phosphate au-delâ
du point de microponction de Ia fin du tube proximal est plus
nettement inhibCe par l'hormone parathyroldienne que par
l'acétazolamide.
Beck and Goldberg administered acetazolamide, a
carbonic anhydrase inhibitor, to thyroparathyroid-
ectomized (TPTX) dogs and found an inhibition of
sodium, phosphate and water reabsorption in the
proximal tubule similar to that seen following para-
thyroid hormone (PTH) administration [1]. Re-
cently, Beck et al have reported that PTH inhibits
carbonic anhydrase specifically in renal cortex in vitro
[2]. They suggested that the inhibition of phosphate
reabsorption by the proximal tubule after the admin-
istration of PTH might be mediated through the in-
hibition of carbonic anhydrase. To test this hypoth-
esis, studies were designed to evaluate the additive
effects of acetazolamide and PTH on proximal phos-
phate reabsorption. In addition, recent studies in-
dicate that PTH also inhibits phosphate reabsorption
beyond the point of puncture in the proximal neph-
ron [3]. Therefore, the sites of action of acetazola-
mide on phosphate reabsorption were compared with
those of PTH.
Methods
Mongrel dogs of either sex, maintained on a diet
containing 0.8% phosphate and 1.0% calcium, were
anesthetized with sodium pentobarbital (30 mg/kg),
TPTX and prepared for clearance and micropuncture
measurements as previously described [41.
Group I. Effect of PTH in TPTX dogs in the absence
of acetazolamide. Micropuncture measurements and
clearance determinations were made during three 15-
mm periods starting 120 mm after the dogs were
TPTX. Following control measurements, bovine
PTH extract, 3.3 U/kg prime and 0.1 U/kg/mm, was
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infused for one hour and re-collections were ob-
tained.
Group II. Effect of PTH in TPTX dogs in the pres-
ence of acetazolamide. One hundred minutes follow-
ing TPTX, the dogs were administered sodium aceta-
zolamide (Diamox—Lederle, Pearl River, NY), 15
mg/kg prime followed by 15 mg/kg/hr. Urinary
losses were carefully monitored and quantitatively
replaced by i.v. infusion of bicarbonate Ringer's solu-
tion. Micropuncture measurements and clearance de-
terminations were made during three 15-mm periods
starting 20 mm after initiation of acetazolamide in-
fusion and 120 mm after the dogs were TPTX. Fol-
lowing control measurements, PTH was infused as in
group I and re-collections were obtained.
Group III. Effect of maximal and supramaximal
doses of acetazolamide in TPTX dogs. These animals
were treated identically to those in group II except
that in the experimental periods a dose of acetazola-
mide three times larger than that used in the control
periods was infused instead of PTH to validate the
maximum inhibitory effect on carbonic anhydrase as
reflected by bicarbonate excretion rates.
Late proximal tubules were identified by the use of
lissamine green dye and micropunctured as pre-
viously described [4]. The concentration of inulin in
tubule fluid was determined in duplicate by the mi-
crofluorometric method [5]. The concentration of
phosphate in tubule fluid was determined in triplicate
using the electron probe method of Lechene [6]. Mi-
cropuncture samples were collected in Rochester,
Minnesota, analyzed for inulin and immediately fro-
zen for subsequent analysis by the electron probe
method in Boston.
Blood samples were collected anaerobically from
the femoral artery at the midpoint of the 15-mm urine
collection period. Urine was collected under mineral
oil. Inulin, para-aminohippurate (PAH) and phos-
phate in plasma, ultrafiltrates and urine were meas-
ured with standard methods as previously described
for our laboratory [4]. Blood gas determinations were
made on a pH blood gas analyzer (IL 213) and urine
CO2 content was measured on a microgasometer
(Natelson). Blood and urine bicarbonate concentra-
tions were calculated from the pH and arterial pres-
sure of carbon dioxide (Pco2) values using the Hen-
derson-Hasselbach equation. Student's t test for
paired and unpaired comparisons, as appropriate,
was used for statistical analysis.
Results
Group I. The effects of PTH in TPTX dogs in the
absence of acetazolamide are shown in Table 1. Para-
thyroid hormone increased the fractional excretion of
phosphate from 3.8 + 1.2 to 19.9 + 3.7%, M6.l
+ 3%, p < 0.005. Proximal tubule fluid to plasma
inulin concentration ratios, (TF/P)1, were signifi-
cantly decreased, 0.22 + 0.07, p < 0.025. Tubule
fluid to ultrafiltrate phosphate concentration ratios,
(TF/UF)P, were significantly increased, 0.l2 +
0.03, p < 0.025. The resultant increase in delivery of
phosphate to the point of micropuncture in the prox-
imal tubule, (TF/UF)0/(TF/P)1, of z0.10 0.02
was significant, P < 0.005. There were no significant
changes in plasma phosphate, glomerular filtration
rate (GFR), renal plasma flow (RPF) or blood pres-
sure (BP).
Group II. The effects of PTH in TPTX dogs in the
presence of acetazolamide are shown in Table 2. As
compared with the control (TF/P)1 of 1.91 + 0.18 in
TPTX dogs in group I, the administration of aceta-
zolamide significantly decreased (TF/P)1 to 1.30 +
0.04, P < 0.005. Similarly, the (TF/UF)0 was signifi-
cantly increased in the presence of acetazolamide.
Consequently, the fraction of filtered phosphate at
the point of micropuncture in the proximal tubule
was markedly higher in the presence of acetazola-
mide, 0.50 + 0.04, as compared with 0.28 + 0.02 in
Table 1. Effect of bPTH in TPTX dogs in the absence of a carbonic anhydrase inhibitor
(TF/UF)PGFR RPF BP
mi/mm mi/join tnmHg (TF/P)1 (TF/UF)P (TF/P)1 FEE, %Dog Wt Tubules ______________ _______________________________________________________________________
No. kg N TPTX PTH TPTX PTH TPTX PTH TPTX PTH TPTX PTH TPTX PTH TPTX PTH
I 19 4 40 43 126 107 III 113 1.76 1.70 0.44 0.64 0.25 0.38 3.4 27.0
2 18 3 37 46 124 119 113 113 2.03 1.73 0.55 0.49 0.27 0.28 8.5 35.3
3 19 4 27 27 96 114 118 120 1.84 1.44 0.40 0.60 0.22 0.42 2.0 28.0
4 15 4 45 61 113 106 136 135 1.22 1.35 0.44 0.55 0.36 0.41 0.8 6.1
5 14 4 19 18 59 49 118 115 1.44 1.57 0.39 0.62 0.27 0.39 5.7 18.9
6 IS 3 22 20 79 92 109 lii 2.97 2.93 0.55 0.69 0.19 0.24 8.1 24.0
7 18 4 35 30 108 70 170 153 2.04 1.45 0.7! 0.73 0.35 0.50 0.2 12.2
8 16 5 47 35 120 103 139 135 2.00 1.3! 0.4! 0.54 0.27 0.4! 1.7 7.8
Mean 34 35 103 95 127 124 1.91 1.69 0.49 0.61 0.28 0.38 3.8 19.9
I SEM 3.6 5.2 8 9 7 5 0.18 0.19 0.04 0.03 0.02 0.03 1.2 3.7
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Table 2. Effectof bPTH in TPTX dogs in the presence of a carbonic anhydrase inhibitor
Dog
No.
Wt
kg
Tubules
N
GFR
mi/rain
TPTX PTH
RPF
mi/rain
TPTX PTH
BP
mmHg
TPTX PTH
(TF/P)1
TPTX PTH
(TF/UF)
TPTX PTH
(TF/UF)
(TF/P)Lfl
TPTX PTH
FEE, %
TPTX PTH
FEHCO3,%
TPTX PTH
9 26 3 34 44 116 129 128 128 1.34 1.56 — — — — 0.2 30.6 12.6 15.5
10 17 3 31 27 148 114 126 109 1.27 1.37 0.68 0.76 0.54 0.55 12.7 28.8 23.5 15.0
11 14 2 28 29 84 124 152 155 1.25 1.43 0.78 0.97 0.62 0.68 22.0 43.1 18.4 25.0
12 14 2 31 27 69 82 93 95 1.28 1.28 0.58 0.61 0.45 0.48 8.5 23.0 22.6 28.9
13 13 3 2! 29 III 118 125 123 1.20 1.20 0.47 0.70 0.39 0.59 2.7 31.5 32.1 24.4
14 18 4 22 25 77 92 138 129 1.46 1.33 0.68 0.61 0.47 0.46 11.7 57.7 36.3 37.1
IS 14 3 30 30 84 78 122 127 1.03 1.16 0.55 0.68 0.53 0.59 8.4 28.4 19.2 17.5
16 IS 4 13 17 52 49 123 112 1.54 1.45 — — — — 1.3 15.5 42.6 36.4
17 16 6 27 23 141 140 120 118 1.28 1.30 0.59 0.60 0.46 0.46 20.2 59.0 20.2 22.7
18 14 3 18 20 65 79 123 122 1.20 1.31 0.91 1.33 0.76 1.02 13.1 20.1 39.2 31.6
19 15 4 25 23 80 96 138 136 1.31 1.24 0.57 0.64 0.44 0.52 3.7 18.4 27.3 19.5
20 18 4 17 17 65 57 113 III 1.47 1.32 0.45 0.64 0.31 0.48 0.3 16.0 34.3 38.4
Mean 25 26 91 97 125 122 1.30 1.33 0.63 0.75 0.50 0.58 8.7 31.0 27.4 26.1
1 SEM 1.9 2.1 9 8 4 4 0.04 0.03 0.04 0.06 0.04 0.05 2.1 4.3 2.7 2.4
the absence of acetazolamide, P < 0.001. Although
the fractional excretion of phosphate showed the
same trend, the difference between groups I and II,
4.94 + 2.8%, was not statistically significant. Finally,
as would be expected, the administration of acetazola-
mide markedly increased fractional bicarbonate ex-
cretion to 27.4 + 2.7% of the filtered load.
The administration of PTH in the presence of
acetazolamide did not significantly change (TF/P)1
but (TF/UF)0 was significantly increased, z0.l2
0.04, P < 0.025. Similarly, the fraction of filtered
phosphate at the point of micropuncture in the prox-
imal tubule was significantly increased, 0.08 +
0.03, P < 0.025. Fractional phosphate excretion was
increased 22.3 + 3.3%, P < 0.001. Following ad-
ministration of PTH there were no significant
changes in plasma phosphate, GFR, RPF, BP or
fractional excretion of bicarbonate. The plasma bi-
carbonate concentration was slightly but significantly
decreased, 2.5 + 0.7 mmoles/liter, P < 0.01, follow-
ing PTH administration.
Group III. The effects of maximal and supramax-
imal doses of acetazolamide in TPTX dogs were
tested in 29 tubules in six dogs. The finding of pre-
vious studies [7] indicating that the dose of 15 mg/kg
was maximal in terms of producing a bicarbonaturia
was confirmed under the present experimental condi-
tions by the administration of a subsequent dose of
45 mg/kg. There were no significant changes in GFR,
22 + 2.7 to 24 3.9 mI/mm; BP, 137 3.4 to 135 +
4.1 mm Hg; (TF/P)1, 1.34 0.08 to 1.37 0.14;(TF/UF)P, 0.63 + 0.03 to 0.64 0.03; fractional
delivery of phosphate at the point of micropuncture,
0.48 + 0.03 to 0.50 0.04; fractional excretion of
phosphate, 13,0 + 3.7 to 14.8 3.6%; or fractional
excretion of bicarbonate, 31.3 + 7.5 to 29.3 + 4.4%.
Discussion
The effects of acetazolamide on phosphate reab-
sorption by the proximal tubule were qualitatively
similar to the effects of PTH. Both increased
(TF/UF)0, decreased (TF/P)1 and increased the de-
livery of phosphate at the point of micropuncture in
the late proximal tubule. Although acetazolamide in-
creased delivery of phosphate from the late proximal
tubule to approximately 50% of the filtered load, only
8.7 and 13% appeared in the urine in group II and
group III experiments, respectively (Fig. 1). In con-
trast, PTH increased delivery of phosphate to 38% of
the filtered load and increased the urinary excretion
of phosphate to 20%. Similarly, in the presence of
acetazolamide, PTH increased the urinary excretion
of phosphate to 31%. These findings indicate that
phosphate reabsorption beyond the point of micro-
puncture is much more markedly inhibited by PTH
than by acetazolamide. A distal reabsorptive capacity
for phosphate was first suggested by Amiel, Kuntzi-
ger and Richet on the basis of comparisons of seg-
mental phosphate reabsorption in TPTX rats with
intact rats [8]. Subsequently, we demonstrated that
phosphate reabsorption beyond the point of micro-
puncture in the proximal tubule could be inhibited by
the administration of PTH to TPTX dogs [3].
There was no significant effect of PTH on isotonic
volume reabsorption in the presence of acetazola-
mide. This finding could be due to the fact that aceta-
zolamide markedly decreased volume reabsorption
so that an additional effect of PTH was masked by
the insensitivity of the methods in this low range. On
the other hand, it is possible that the effects of PTH
on isotonic volume reabsorption by the proximal tu-
bule might be mediated by inhibition of carbonic
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Proximal phosphate concentration anhydrase. Parathyroid hormone has been shown to
0.80 - I increase urinary bicarbonate excretion [9—16], and
4 this effect could be mediated through inhibition of
—' I carbonic anhydrase activity. Although PTH did not
significantly increase in urinary bicarbonate excretion
in the presence of acetazolamide, the very high excre-0.60 -
.....
I tion rates of bicarbonate may have masked the rela-
tively small effects of PTH on bicarbonate excretion.
Alternatively, the failure to see an effect of PTH on
bicarbonate excretion in the presence of acetazola-
040 mide may have been due to a common mechanism ofCarbonic anhydrase inhibition action for the two agents. In contrast, PTH signifi-
Present, 10 dogs cantly increased (TF/UF)0 delivery of phosphate
from the proximal tubule and fractional excretion of
phosphate in the urine in the presence of acetazola-
A
0
TPTX b PTH mide (Fig. 1). This additive effect of acetazolamide
and PTH on renal phosphate handling indicates that
these two agents have different mechanisms and sites
Proximal phosphate delivery of action. In the presence of acetazolamide, it is Un-
0.60 likely that the effects of PTH on phosphate reabsorp-
tion were due to additional inhibition of carbonic
anhydrase since control studies with higher doses of
I acetazolamide did not mimic the effect of PTH, How-
ever, the possibility that PTH might inhibit carbonic
0.40 anhydrase activity through a different receptor mech-
• anism than that associated with acetazolamide can-
not be ruled out from the present studies.
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